Aerovate Therapeutics Inc (AVTE)
NASDAQ
Fin d'année 31 Décembre 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -189.528 | -233.589 | -25.503 | -33.162 | -57.492 |
Return on Equity (%) | 182.816 | 113.157 | -28.871 | -34.437 | -63.947 |
Return on Invested Capital (%) | -233.182 | -306.623 | -26.306 | -35.952 | -70.424 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 11.855 | 12.103 | 7.063 | 5.127 | 3.956 |
Earnings Per Share | -13.817 | -39.551 | -0.941 | -2.084 | -2.729 |
Cash Per Share | 14.581 | 18.819 | 2.22 | 0.906 | 0.849 |
Working Capital Per Share | 11.855 | 11.942 | 7.037 | 5.004 | 3.853 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -13.813 | -39.551 | -0.941 | -2.083 | -2.727 |
EBITDA Per Share | -13.813 | -39.551 | -0.941 | -2.083 | -2.727 |
Free Cash Flow Per Share | -13.817 | -39.556 | -0.934 | -2.078 | -2.728 |
Fin d'année 31 Décembre 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 241k | 243k | 24,41M | 24,72M | N/A |
Fin d'année 31 Décembre 2023 | Juin 2022 | Sept 2022 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||||
Actions en circulation | 24,42M | 24,51M | 24,72M | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 56,44M |
Ratio cours/bénéfice | -0,75 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 2,4 |
Ratio prix/valeur comptable | 0,51 |
Rendement de dividende | - |
Actions en circulation | 28,87M |
Volume moyen (1 semaine) | 311,44k |
Volume moyen (1 mois) | 230,81k |
Variation sur 52 semaines | -85,36% |
Plus haut sur 52 semaines | 32,415 |
Plus bas sur 52 semaines | 1,25 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales